|
KR100859972B1
(ko)
|
2006-02-20 |
2008-09-25 |
이화여자대학교 산학협력단 |
막투과 단백질 도메인 펩타이드
|
|
KR101169030B1
(ko)
*
|
2009-01-21 |
2012-07-26 |
애니젠 주식회사 |
신규한 세포막 투과 도메인 및 이를 포함하는 세포내 전달 시스템
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2625189B1
(en)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DE19216461T1
(de)
|
2011-10-03 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
|
|
CA3018046A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
ES2691070T3
(es)
|
2012-05-11 |
2018-11-23 |
Kael-Gemvax Co.,Ltd |
Péptidos antiinflamatorios y composición que comprende los mismos
|
|
WO2013169060A1
(ko)
|
2012-05-11 |
2013-11-14 |
주식회사 카엘젬백스 |
패혈증 예방 또는 치료용 조성물
|
|
ES2981865T3
(es)
|
2012-07-11 |
2024-10-10 |
Gemvax & Kael Co Ltd |
Conjugado que comprende un péptido de penetración celular y composiciones que comprenden el mismo
|
|
TWI616531B
(zh)
|
2012-09-19 |
2018-03-01 |
傑姆維克斯＆凱爾有限公司 |
穿膜胜肽以及包含該胜肽之共軛物及組成物（二）
|
|
US9631184B2
(en)
|
2012-09-19 |
2017-04-25 |
Gemvax & Kael Co., Ltd. |
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
|
|
PL2922554T3
(pl)
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
|
KR101495417B1
(ko)
*
|
2013-01-31 |
2015-02-26 |
이화여자대학교 산학협력단 |
인슐린 점막 투과 개선용 조성물
|
|
WO2014152211A1
(en)
|
2013-03-14 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
KR101595152B1
(ko)
*
|
2013-04-10 |
2016-02-17 |
이화여자대학교 산학협력단 |
Ｔｃｔｐ-ｐｔｄ를 포함하는 유전자 전달체
|
|
KR102258864B1
(ko)
|
2013-04-19 |
2021-06-01 |
주식회사 젬백스앤카엘 |
허혈성 손상 치료 및 예방용 조성물
|
|
KR101491016B1
(ko)
*
|
2013-05-31 |
2015-02-10 |
건국대학교 산학협력단 |
배반포 및 생식기관 암 세포 특이적인 단백질 운반 방법 및 그 조성물
|
|
RU2677277C2
(ru)
|
2013-06-07 |
2019-01-16 |
Джемвакс Энд Каэл Ко., Лтд. |
Биологические маркеры, которые могут быть использованы в иммунотерапии рака
|
|
TWI539960B
(zh)
|
2013-06-21 |
2016-07-01 |
凱爾傑姆維克斯有限公司 |
激素分泌調節劑、包括其的組成物以及其用途
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
EP3041934A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
CA2926183C
(en)
|
2013-10-23 |
2018-07-03 |
Gemvax & Kael Co., Ltd. |
Composition for treating and preventing benign prostatic hyperplasia
|
|
GB201318954D0
(en)
*
|
2013-10-28 |
2013-12-11 |
Cupid Peptide Company Ltd |
Cell transport
|
|
EP3072519B1
(en)
|
2013-11-22 |
2020-08-19 |
Gemvax & Kael Co., Ltd. |
Peptide having angiogenesis inhibitory activity and composition containing same
|
|
CN113481217A
(zh)
|
2013-12-13 |
2021-10-08 |
巴斯夫欧洲公司 |
用于精细化学品的改进生产的重组微生物
|
|
ES2809251T3
(es)
|
2013-12-17 |
2021-03-03 |
Gemvax & Kael Co Ltd |
Composición para tratar cáncer de próstata
|
|
JP6420459B2
(ja)
|
2014-04-11 |
2018-11-07 |
ジェムバックス アンド カエル カンパニー，リミティド |
線維症抑制活性を有するペプチド及びこれを含む組成物
|
|
US10662223B2
(en)
|
2014-04-30 |
2020-05-26 |
Gemvax & Kael Co., Ltd. |
Composition for organ, tissue, or cell transplantation, kit, and transplantation method
|
|
JP6807831B2
(ja)
*
|
2014-05-21 |
2021-01-06 |
エントラーダ セラピューティクス，インコーポレイテッド |
細胞膜透過性ペプチド、並びにこの作製方法及び使用方法
|
|
KR101804291B1
(ko)
|
2014-06-16 |
2018-01-10 |
이화여자대학교 산학협력단 |
TCTP 이량체형 IgE-의존성 히스타민 방출인자와 이의 수용체간의 결합을 억제하는 TCTP 유래 FL 도메인 및 이의 용도
|
|
EP3171895A1
(en)
|
2014-07-23 |
2017-05-31 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
KR102413243B1
(ko)
|
2014-12-23 |
2022-06-27 |
주식회사 젬백스앤카엘 |
안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
|
|
KR102636129B1
(ko)
|
2015-02-27 |
2024-02-14 |
주식회사 젬백스앤카엘 |
청력 손상 방어용 펩타이드 및 이를 포함하는 조성물
|
|
WO2016190660A1
(ko)
|
2015-05-26 |
2016-12-01 |
주식회사 젬백스앤카엘 |
신규 펩티드 및 이를 포함한 조성물
|
|
EP3318265B1
(en)
|
2015-07-02 |
2021-08-18 |
Gemvax & Kael Co., Ltd. |
Peptide having anti-viral effect and composition containing same
|
|
EP3336098B1
(en)
*
|
2015-09-10 |
2021-08-11 |
IUCF-HYU (Industry-University Cooperation Foundation Hanyang University) |
Skin permeable peptide and method for using same
|
|
EP3371212B1
(en)
|
2015-11-06 |
2023-10-11 |
The Board of Trustees of the University of Illinois |
Peptides and method for treatment of cardiac arrest
|
|
CN116082457A
(zh)
|
2016-02-01 |
2023-05-09 |
堪培拉大学 |
蛋白化合物及其用途
|
|
WO2017176076A1
(en)
|
2016-04-06 |
2017-10-12 |
Ewha University - Industry Collaboration Foundation |
A peptide with ability to penetrate cell membrane
|
|
US10918727B2
(en)
|
2016-04-06 |
2021-02-16 |
Icure Bnp Co., Ltd. |
Peptide with ability to penetrate cell membrane
|
|
EP4272829A3
(en)
|
2016-04-07 |
2024-01-17 |
Gemvax & Kael Co., Ltd. |
Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same
|
|
CN110139870B
(zh)
*
|
2016-12-16 |
2023-12-01 |
爱维斯健有限公司 |
细胞膜穿透肽及包含其的细胞内输送载体
|
|
US11485972B2
(en)
|
2017-05-18 |
2022-11-01 |
Modernatx, Inc. |
Modified messenger RNA comprising functional RNA elements
|
|
JP7285220B2
(ja)
|
2017-05-18 |
2023-06-01 |
モデルナティエックス インコーポレイテッド |
連結したインターロイキン－１２（ｉｌ１２）ポリペプチドをコードするポリヌクレオチドを含む脂質ナノ粒子
|
|
EP3638292A1
(en)
|
2017-06-14 |
2020-04-22 |
ModernaTX, Inc. |
Polynucleotides encoding coagulation factor viii
|
|
CA3177086A1
(en)
|
2017-06-22 |
2018-12-27 |
Catalyst Biosciences, Inc. |
Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use
|
|
WO2019036753A1
(en)
|
2017-08-22 |
2019-02-28 |
Monash University |
SCREENING TESTS, MODULATORS AND MODULATION OF RECEIVER ACTIVATION FOR ADVANCED GLYCATION TERMINAL PRODUCTS (RAGE)
|
|
WO2019090390A1
(en)
|
2017-11-08 |
2019-05-16 |
University Of Canberra |
Immunogenic compositions and uses therefor
|
|
EP3714045A1
(en)
|
2017-11-22 |
2020-09-30 |
Modernatx, Inc. |
Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia
|
|
CA3079428A1
(en)
|
2017-11-22 |
2019-05-31 |
Modernatx, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
|
US11939601B2
(en)
|
2017-11-22 |
2024-03-26 |
Modernatx, Inc. |
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
|
|
KR101933217B1
(ko)
|
2017-12-28 |
2018-12-27 |
(주) 에빅스젠 |
피부 염증 억제용 펩티드 및 이를 포함하는 피부 염증 예방 또는 치료용 조성물
|
|
MA51523A
(fr)
|
2018-01-05 |
2020-11-11 |
Modernatx Inc |
Polynucléotides codant pour des anticorps anti-virus du chikungunya
|
|
US11987647B2
(en)
|
2018-05-09 |
2024-05-21 |
Ohio State Innovation Foundation |
Cyclic cell-penetrating peptides with one or more hydrophobic residues
|
|
WO2019226650A1
(en)
|
2018-05-23 |
2019-11-28 |
Modernatx, Inc. |
Delivery of dna
|
|
US20220184185A1
(en)
|
2018-07-25 |
2022-06-16 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
|
US10842827B2
(en)
*
|
2018-08-22 |
2020-11-24 |
José Manuel Aguilar Yáñez |
Treatment and compound for epithelial wounds
|
|
WO2020047201A1
(en)
|
2018-09-02 |
2020-03-05 |
Modernatx, Inc. |
Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency
|
|
WO2020056155A2
(en)
|
2018-09-13 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease
|
|
MX2021003015A
(es)
|
2018-09-13 |
2021-07-15 |
Modernatx Inc |
Polinucleotidos que codifican glucosa-6-fosfatasa para el tratamiento de la glucogenosis.
|
|
JP2022500444A
(ja)
|
2018-09-14 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
クリグラー−ナジャー症候群の治療のためのウリジン二リン酸グリコシルトランスフェラーゼ１ファミリー、ポリペプチドａ１をコードするポリヌクレオチド
|
|
EP3856233A1
(en)
|
2018-09-27 |
2021-08-04 |
Modernatx, Inc. |
Polynucleotides encoding arginase 1 for the treatment of arginase deficiency
|
|
US11613744B2
(en)
|
2018-12-28 |
2023-03-28 |
Vertex Pharmaceuticals Incorporated |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
|
CA3123872A1
(en)
|
2018-12-28 |
2020-07-02 |
Catalyst Biosciences, Inc. |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
|
AU2020232238B2
(en)
|
2019-03-01 |
2025-10-30 |
Flagship Pioneering Innovations Vi, Llc |
Polyribonucleotides and cosmetic uses thereof
|
|
MA55082A
(fr)
|
2019-03-01 |
2022-01-05 |
Flagship Pioneering Innovations Vi Llc |
Compositions, procédés, et kits pour l'administration de polyribonucléotides
|
|
JP2022532078A
(ja)
|
2019-05-08 |
2022-07-13 |
アストラゼネカ アクチボラグ |
皮膚及び創傷のための組成物並びにその使用の方法
|
|
CN112694522B
(zh)
*
|
2020-03-11 |
2022-06-14 |
浙江大学 |
一种基于GluN2A亚基的细胞穿膜肽及其应用
|
|
KR102274999B1
(ko)
*
|
2020-04-23 |
2021-07-08 |
주식회사 아임뉴런바이오사이언스 |
신규한 세포 투과성 펩타이드 및 이의 용도
|
|
EP4153223A1
(en)
|
2020-05-20 |
2023-03-29 |
Flagship Pioneering Innovations VI, LLC |
Immunogenic compositions and uses thereof
|
|
EP4158005A1
(en)
|
2020-06-01 |
2023-04-05 |
ModernaTX, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
|
AU2021336976A1
(en)
|
2020-09-03 |
2023-03-23 |
Flagship Pioneering Innovations Vi, Llc |
Immunogenic compositions and uses thereof
|
|
WO2022104131A1
(en)
|
2020-11-13 |
2022-05-19 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
KR20220085522A
(ko)
*
|
2020-12-15 |
2022-06-22 |
주식회사 아이큐어비앤피 |
세포막 투과성을 갖는 신규 펩타이드
|
|
US20240207374A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
|
US20240226025A1
(en)
|
2021-03-24 |
2024-07-11 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
|
WO2022204390A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
|
WO2022204370A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
|
|
US20240216288A1
(en)
|
2021-03-24 |
2024-07-04 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
|
KR20220157778A
(ko)
*
|
2021-05-21 |
2022-11-29 |
원큐어젠 주식회사 |
세포 투과성 펩타이드 및 글루카곤 유사 펩타이드-1 수용체 작용제를 포함하는 복합체
|
|
EP4355882A2
(en)
|
2021-06-15 |
2024-04-24 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
|
WO2022271776A1
(en)
|
2021-06-22 |
2022-12-29 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
WO2023056044A1
(en)
|
2021-10-01 |
2023-04-06 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
JP2024536505A
(ja)
*
|
2021-10-13 |
2024-10-04 |
キャンプ セラピューティクス インク |
ナノモル濃度で細胞内に伝達可能なミトコンドリア特異的ペプチド及びその用途
|
|
KR20230061895A
(ko)
*
|
2021-10-29 |
2023-05-09 |
주식회사 아이큐어비앤피 |
지질 나노입자 및 세포 투과성을 갖는 신규 펩타이드의 복합체
|
|
US20250221931A1
(en)
|
2022-03-25 |
2025-07-10 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
|
WO2024026254A1
(en)
|
2022-07-26 |
2024-02-01 |
Modernatx, Inc. |
Engineered polynucleotides for temporal control of expression
|
|
WO2024117321A1
(ko)
*
|
2022-12-01 |
2024-06-06 |
㈜에빅스젠 |
세포막 투과 펩티드 및 이를 포함하는 세포내 전달체
|
|
WO2024197033A1
(en)
|
2023-03-21 |
2024-09-26 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of heart failure
|
|
EP4704816A1
(en)
|
2023-05-03 |
2026-03-11 |
ModernaTX, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
JP7723457B2
(ja)
*
|
2023-07-03 |
2025-08-14 |
メスキュージェナシス株式会社 |
細胞膜透過性を有するペプチドおよびそのスクリーニング方法
|
|
WO2025072482A1
(en)
|
2023-09-27 |
2025-04-03 |
Modernatx, Inc. |
Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof
|
|
WO2025255199A1
(en)
|
2024-06-05 |
2025-12-11 |
Modernatx, Inc. |
Argininosuccinate synthase 1 and argininosuccinate lyase polypeptides and polynucleotides and uses thereof
|